Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)

Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)

This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Chuai Y, Rizzuto I, Zhang X, Li Y, Dai G, Otter SJ, Bharathan R, Stewart A, Wang A; Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic...

Full description

Bibliographic Details
Main Author: Tatiana A. Staroverova
Format: Article
Language:Russian
Published: IP Habib O.N. 2022-04-01
Series:Современная онкология
Subjects:
angiogenesis inhibitors
antineoplastic agents
bevacizumab
bias
brachytherapy
combined modality therapy
confidence intervals
gastric fistula
gastrointestinal hemorrhage
hypertension
indazoles
intestinal fistula
intestinal perforation
lapatinib
neoplasm recurrence local
progression-free survival
pyridines
pyrimidines
quality of life
quinazolines
randomized controlled trials as topic
sulfonamides
thromboembolism
uterine cervical neoplasms
vascular endothelial growth factor a
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/106975/81314
Description
Summary:This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Chuai Y, Rizzuto I, Zhang X, Li Y, Dai G, Otter SJ, Bharathan R, Stewart A, Wang A; Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer; Version published: 04 March 2021; DOI: 10;1002/14651858;CD013348;pub2
ISSN:1815-1434
1815-1442

Similar Items